Microbion has reported positive topline results from its Phase II study of pravibismane, a topical treatment for DFI.
Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s comment caused a $12bn market wipe.
Eli Lilly has reported comprehensive outcomes from the SURMOUNT-1 study of tirzepatide for treating pre-diabetic and obese ...
The DACH region encompasses Germany, Austria, and Switzerland. Credit: Tom Korcak via Shutterstock. Amid tightening EU ...
Intelligent Bio Solutions plans to file for 510(k) clearance with the US FDA in Q4 this year. Image credit: PRESSLAB / Shutterstock. US based company Intelligent Bio Solutions has released “strong ...